Now showing items 1-9 of 9
Novel Psychoactive Substances: Policy, Economics and Drug Regulation
The use of supplements and performance and image enhancing drugs in fitness settings: a cross‐sectional investigation in the United Kingdom
Objective: The strive for perfection is prevalent in the fitness industry. This study aimed to explore the use of products to enhance performance alongside exposure to exercise addiction (EA), appearance anxiety and ...
Can mobile phone technology support a rapid sharing of information on Novel Psychoactive Substances among health and other professionals internationally?
Background The diffusion of Novel Psychoactive Substances (NPSs), combined with the ability of the Internet to act as an online marketplace, has led to unprecedented challenges for governments, health agencies, and substance ...
Changing Trends in the Use of Kratom (Mitragyna speciosa) in Southeast Asia
Objective: Kratom (Mitragyna speciosa. Korth) is an indigenous medicinal plant of Southeast Asia. This review paper aims to describe the trends of kratom use in Southeast Asia, particularly, in Malaysia and Thailand, where ...
Hair analysis for the detection of drug use – is there potential for evasion?
BACKGROUND: Hair analysis for illicit substances is widely used to detect chronic drug consumption or abstention from drugs. Testees are increasingly seeking ways to avoid detection by using a variety of untested adulterant ...
Captagon: Use and Trade in the Middle East
Fenetheylline, a psychostimulant drug, often branded as Captagon, is a combination of amphetamine and theophylline. Since the cessation of its legal production in 1986, counterfeited products have been produced illicitly ...
Synthetic Cannabinoids : psychopharmacology, clinical aspects, and psy-chotic onset
Synthetic Cannabinoids (SC) are the widest and most diffused class of Novel Psychoactive Substances. SC are chemically heterogeneous and structurally dissimilar from delta-9-tetrahydrocannabinol, being full agonists of the ...